The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: Recommendations for sentinel lymph node biopsy

Journal of the American College of Surgeons

Volumn 197, Issue 3, 2003, Pages 403-407

  Zapas, John L ^a,b   Coley, H Christopher ^a   Beam, Sandra L ^a   Brown, Sally D ^a   Jablonski, Kathleen A ^a   Elias, E George ^a  

^a Franklin Square Hospital Center   (United States)

^b NONE   (United States)

Author keywords

IHC; Immunohistochemical; LN; Lymph node; Sentinel lymph node; SLN

Indexed keywords

ADULT; AGED; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN CARCINOMA; SKIN SURGERY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UNITED STATES; ADOLESCENT; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; MIDDLE AGED; PATHOLOGY; SKIN TUMOR; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 0141610028     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(03)00432-0     Document Type: Article

References (16)

1. Reintgen D. Establishing a standard of care for the patient with melanoma. Ann Surg Oncol. 8:2001;91.
2. Dessureault S., Soong S.-J., Ross M.I., et al. Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol. 8:2001;766-770.
3. Lamberg L. "Epidemic" of malignant melanoma true increase or better detection? JAMA. 287:2002;2201.
4. Shivers S.C., Wang X., Li W., et al. Molecular staging of malignant melanoma, correlation with clinical outcome. JAMA. 280:1998;1410-1415.
5. Bleicher R.J., Essner R., Foshag L.J., et al. Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. J Clin Oncol. 21:2003;1326-1331.
6. Bedrosian I., Faries M.B., Guerry D. IV, et al. Incidence of sentinel node metastasis in patients with thin primary melanoma (≤1 mm) with vertical growth phase. Ann Surg Oncol. 7:2000;262-267.
7. Corsetti R.L., Allen H.M., Wanebo H.J. Thin ≤1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy. Ann Surg Oncol. 7:2000;456-460.
8. Statius Muller M.G., van Leeuwen P.A.M., van Diest P.J., et al. No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness less than 0.9 mm. Melanoma Res. 11:2001;303-307.
9. Bostick P.J., Morton D.L., Turner R.R., et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol. 17:1999;3238-3244.
10. Palmieri G., Ascierto P.A., Cossu A., et al. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay. J Clin Oncol. 19:2001;11433-11437.
11. Bieligk S.C., Ghossein R., Bhattacharya S., Coit D.G. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol. 6:1999;232-240.
12. Li W., Stall A., Shivers S.C., et al. Clinical relevance of molecular staging for melanoma comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma. Ann Surg. 231:2000;795-803.
13. Shivers S.C., Li W., Haddad F., Reintgen D.S. Molecular staging of melanoma. Ann Surg Oncol. 6:1999;225-226.
14. Bachter D., Michl C., Büchels H., et al. The predictive value of the sentinel lymph node in malignant melanomas. Recent Results Cancer Res. 158:2001;129-136.
15. Landi G., Polverelli M., Moscatelli G., et al. Sentinel lymph node biopsy in patients with primary cutaneous melanoma study of 455 cases. J Euro Acad Dermatol Venereol. 14:2000;35-45.
16. Cook M.G., Spatz A., Brocker E.B., Ruiter D.J. Identification of histological features associated with metastatic potential in thin (less than 1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group. J Pathol. 197:2002;188-193.